Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9274279 | PMC |
| http://dx.doi.org/10.3389/fonc.2022.880497 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Techniques of Oncovascular Reconstruction of Portal and Mesenteric Veins during Pancreatic and Hepatobiliary Surgery.
Vasc Specialist Int
December 2024
Division of Vascular Surgery, Department of Surgery, Seoul National University College of Medicine, Seoul, Korea.
Major vessel invasion, particularly involving the portal and superior mesenteric veins, poses significant challenges during the radical resection of hepatobiliary and pancreatic cancers. Oncovascular surgery is essential for curative outcomes, and often requires portomesenteric vein reconstruction. Techniques, such as lateral venorrhaphy, patch repair, end-to-end anastomosis, and interposition grafting, have been employed.
View Article and Find Full Text PDFInvited Commentary: Ten-Year Outcome of a Randomized Trial: Cytoreduction and HIPEC with Mitomycin C Versus Oxaliplatin for Appendiceal Neoplasm with Peritoneal Dissemination, by Levine et al.
Ann Surg Oncol
December 2024
Surgical Oncology, Rutgers Cancer Institute, New Brunswick, NJ, USA.
What is the optimal dialysis method for diabetic patients with end stage kidney disease?
World J Diabetes
December 2024
Department of Nursing & Midwifery Research, Hamad Medical Corporation, Doha 3050, Qatar.
Article Synopsis
- Diabetes significantly contributes to the rising rates of end-stage kidney disease (ESKD), with kidney transplants being limited due to a shortage of donors.
- Dialysis serves as the primary alternative for ESKD treatment, but diabetic patients face additional complications, including infections and blood glucose level fluctuations.
- The article reviews various dialysis methods and presents evidence-based studies to recommend the most effective type of dialysis for diabetic ESKD patients.
Pharmacokinetic studies in dialysis-dependent patients: limited data availability.
Expert Opin Drug Metab Toxicol
December 2024
Renal Pharmacy Consultants, LLC, Saline, MI, USA.
Comparative iron management in hemodialysis and peritoneal dialysis patients: a systematic review.
Front Nephrol
November 2024
Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, Netherlands.
Background: Patients with kidney failure undergoing dialysis often suffer from anemia. Iron deficiency, along with a shortage in erythropoietin, is a common cause. Peritoneal dialysis (PD) patients may have a different iron metabolism compared to hemodialysis (HD) patients.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!